ACVR1: Activin receptor type-1
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Bone morphogenetic protein (BMP) type I receptor that is involved in a wide variety of biological processes, including bone, heart, cartilage, nervous, and reproductive system development and regulation.
- Drugs that act on it: 4
- With a US drug page: 2
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Momelotinib | Approved | Activin receptor type-1 inhibitor | Inhibitor | — |
| Pacritinib | Approved | Activin receptor type-1 inhibitor | Inhibitor | — |
| Dibotermin alfa | — | Activin receptor type-1 agonist | Agonist | — |
| Eptotermin alfa | — | Activin receptor type-1 agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Myelofibrosis
- 0.56
- Neoplasm
- 0.51
- Neurodegenerative disease
- 0.48
- Hereditary disease
- 0.47
- Bone disorder
- 0.46
- Tibia fracture
- 0.46
- Myeloproliferative disorder
- 0.41
- Acquired polycythemia vera
- 0.40
- Splenomegaly
- 0.37
Drugs and mechanisms are from ChEMBL CHEMBL5903 (CC BY-SA 3.0). Gene name, function (UniProt Q04771, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets